BK polyomavirus from patients with tissue-derived prostate adenocarcinoma

Future Virology

Volumn 8, Issue 3, 2013, Pages 313-320

  Zhong, Shan ^a   Suzuki, Makoto ^b   Peng, Xu ^c   Shen, Zhou Jun ^a   Wang, Xian Jin ^a   Xu, Tian Yuan ^a   Li, Tao ^a   Yogo, Yoshiaki ^b   Homma, Yukio ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c Texas AandM Healthy Science Center   (United States)

Author keywords

BK virus; PCR; prostate; prostatic neoplasms

Indexed keywords

HEMOGLOBIN BETA CHAIN;

ADULT; BK VIRUS; CANCER GROWTH; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; TRANSURETHRAL RESECTION;

EID: 84874755280     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.13.8     Document Type: Review

References (28)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1(7712), 1253-1257 (1971).
2. Knowles W. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: Human polyomaviruses: molecular and clinical perspectives. Khalili K, Stoner GL (Eds), John Wiley & Sons, NY, USA, 527-559 (2001).
3. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect. Dis. 3(10), 611-623 (2003).
4. Moens U, Rekvig OP. Molecular biology of BK virus and clinical and basic aspects of BK virus renal infection. In: Human Polyomaviruses: Molecular and Clinical Perspectives. Khalili K, Stoner GL (Eds). John Wiley & Sons, NY, USA, 359-408 (2001).
5. Dörries K. Latent and persistent polyomavirus infection. In: Human Polyomaviruses: Molecular and Clinical Perspectives. Khalili K, Stoner GL (Eds). John Wiley & Sons, NY, USA, 197-235 (2001).
6. Corallini A, Tognon M, Negrini M et al. Evidence for BK virus as a human tumor virus. In: Human Polyomaviruses: Molecular and Clinical Perspectives. Khalili K, Stoner GL (Eds). John Wiley & Sons, NY, USA, 431-460 (2001).
7. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M. BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors. Adv. Exp. Med. Biol. 577, 319-341 (2006).
8. Lee W, Langhoff E. Polyomavirus in human cancer development. Adv. Exp. Med. Biol. 577, 310-318 (2006).
9. Seif I, Khoury G, Dhar R. The genome of human papovavirus BKV. Cell 18(4), 963-977 (1979).
10. Das D, Shah RB, Imperiale MJ. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23(42), 7031-7046 (2004).
11. Das D, Wojno K, Imperiale MJ. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J. Virol. 82(6), 2705-2714 (2008).
12. Lau SK, Lacey SF, Chen YY, Chen WG, Weiss LM. Low frequency of BK virus in prostatic adenocarcinomas. APMIS 115(6), 743-749 (2007).
13. Russo G, Anzivino E, Fioriti D et al. p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: is there a correlation? J. Med. Virol. 80(12), 2100-2107 (2008).
14. Yogo Y, Sugimoto C, Zhong S, Homma Y. Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications. Rev. Med. Virol. 19(4), 185-199 (2009).
15. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 370(9590), 890-907 (2007).
16. Zur Hausen H. Papillomaviruses in the causation of human cancers -a brief historical account. Virology 384(2), 260-265 (2009).
17. Takasaka T, Goya N, Tokumoto T et al. Subtypes of BK virus prevalent in Japan and variation in their transcriptional control region. J. Gen. Virol. 85(Pt 10), 2821-2827 (2004).
18. Saiki RK, Gelfand DH, Stoffel S et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239(4839), 487-491 (1988).
19. Nishimoto Y, Takasaka T, Hasegawa M et al. Evolution of BK virus based on complete genome data. J. Mol. Evol. 63(3), 341-352 (2006).
20. Jin L, Gibson PE, Booth JC, Clewley JP. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J. Med. Virol. 41(1), 11-17 (1993).
21. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011).
22. Yogo Y, Zhong S, Xu Y et al. Conserved archetypal configuration of the transcriptional control region during the course of BK polyomavirus evolution. J. Gen. Virol. 89(Pt 8), 1849-1856 (2008).
23. Zhong S, Zheng HY, Suzuki M et al. Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J. Clin. Microbial. 45(1), 193-198 (2007).
24. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 302(5903), 21-24 (1983).
25. Theile M, Grabowski G. Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch. Virol. 113(3-4), 221-233 (1990).
26. Tognon M, Casalone R, Martini F et al. Large T antigen coding sequences of two DNA tumor viruses, BK and SV40, and nonrandom chromosome changes in two glioblastoma cell lines. Cancer Genet. Cytogenet. 90(1), 17-23 (1996).
27. Trabanelli C, Corallini A, Gruppioni R et al. Chromosomal aberrations induced by BK virus T antigen in human fibroblasts. Virology 243(2), 492-496 (1998).
28. Sais G, Wyler S, Hudolin T et al. Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia. J. Virol. 86(16), 8461-8471 (2012).